US 11,730,835 B2
Method of preventing the development of melanoma
Peter Novak, Sunny Isles Beach, FL (US); Maxim V. Temnikov, Miami, FL (US); and Oleksandr Balakin, Dnepropetrovsk (UA)
Assigned to Vector Vitale IP LLC, North Miami Beach, FL (US)
Filed by Vector Vitale IP LLC, North Miami Beach, FL (US)
Filed on Oct. 19, 2022, as Appl. No. 17/969,297.
Application 17/969,297 is a continuation of application No. 16/692,584, filed on Nov. 22, 2019, granted, now 11,484,610.
Prior Publication US 2023/0050325 A1, Feb. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 51/04 (2006.01); A61K 31/164 (2006.01); A61P 35/00 (2006.01); A61K 33/30 (2006.01)
CPC A61K 51/0476 (2013.01) [A61K 31/164 (2013.01); A61K 33/30 (2013.01); A61P 35/00 (2018.01)] 9 Claims
 
1. A method of reducing melanoma tumor growth of a primary melanoma in a patient in need thereof, comprising suppressing tumor growth of the primary melanoma by administering a composition comprising a therapeutically effective amount of 64Zne(Asp)2 to said patient, wherein from 0.2 μg/kg to 2000 mg/kg patient weight/day of 64Zne(Asp)2 is administered to the patient and wherein the 64Zne(Asp)2 is at least 90% the L-enantiomer.